CL2012001227A1 - Composicion farmaceutica que comprende un portador de lipidos y al menos dos agentes activos selccionados entre antibioticos, antihongos, antiparasitarios, antivirales, antinflamatorios no esteroideos, analgesicos, anestesicos y esteroides; donde el portador lipidico es una emulsion lipidicadea aceite en agua, una microemulsion lipidica o una vesicula lipidica; uso en la infeccion por otitis externa. - Google Patents

Composicion farmaceutica que comprende un portador de lipidos y al menos dos agentes activos selccionados entre antibioticos, antihongos, antiparasitarios, antivirales, antinflamatorios no esteroideos, analgesicos, anestesicos y esteroides; donde el portador lipidico es una emulsion lipidicadea aceite en agua, una microemulsion lipidica o una vesicula lipidica; uso en la infeccion por otitis externa.

Info

Publication number
CL2012001227A1
CL2012001227A1 CL2012001227A CL2012001227A CL2012001227A1 CL 2012001227 A1 CL2012001227 A1 CL 2012001227A1 CL 2012001227 A CL2012001227 A CL 2012001227A CL 2012001227 A CL2012001227 A CL 2012001227A CL 2012001227 A1 CL2012001227 A1 CL 2012001227A1
Authority
CL
Chile
Prior art keywords
lipid
carrier
infection
pharmaceutical composition
active agents
Prior art date
Application number
CL2012001227A
Other languages
English (en)
Inventor
William R Campbell
Neil E Paulen
Roland H Johnson
Douglas I Hepler
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43992011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012001227(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of CL2012001227A1 publication Critical patent/CL2012001227A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Abstract

Método para tratar o prevenir la infección por otitis externa y las secuelas de la misma mediante una administración tópica; composición farmacéutica que comprende un portador de lípidos y al menos dos agentes activos.
CL2012001227A 2009-11-11 2012-05-10 Composicion farmaceutica que comprende un portador de lipidos y al menos dos agentes activos selccionados entre antibioticos, antihongos, antiparasitarios, antivirales, antinflamatorios no esteroideos, analgesicos, anestesicos y esteroides; donde el portador lipidico es una emulsion lipidicadea aceite en agua, una microemulsion lipidica o una vesicula lipidica; uso en la infeccion por otitis externa. CL2012001227A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26030909P 2009-11-11 2009-11-11

Publications (1)

Publication Number Publication Date
CL2012001227A1 true CL2012001227A1 (es) 2012-08-24

Family

ID=43992011

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001227A CL2012001227A1 (es) 2009-11-11 2012-05-10 Composicion farmaceutica que comprende un portador de lipidos y al menos dos agentes activos selccionados entre antibioticos, antihongos, antiparasitarios, antivirales, antinflamatorios no esteroideos, analgesicos, anestesicos y esteroides; donde el portador lipidico es una emulsion lipidicadea aceite en agua, una microemulsion lipidica o una vesicula lipidica; uso en la infeccion por otitis externa.

Country Status (28)

Country Link
US (1) US8927006B2 (es)
EP (1) EP2498792B1 (es)
JP (2) JP2013510861A (es)
KR (2) KR20120116398A (es)
CN (1) CN102612372B (es)
AU (1) AU2010319538B2 (es)
BR (1) BR112012011017A2 (es)
CA (1) CA2780160C (es)
CL (1) CL2012001227A1 (es)
CO (1) CO6540004A2 (es)
DK (1) DK2498792T3 (es)
EC (1) ECSP12011967A (es)
ES (1) ES2645200T3 (es)
HR (1) HRP20171520T1 (es)
HU (1) HUE034617T2 (es)
IL (1) IL219483A (es)
LT (1) LT2498792T (es)
MX (1) MX2012005521A (es)
MY (1) MY162687A (es)
NO (1) NO2498792T3 (es)
NZ (1) NZ599559A (es)
PL (1) PL2498792T3 (es)
PT (1) PT2498792T (es)
RU (1) RU2680137C2 (es)
SI (1) SI2498792T1 (es)
UA (1) UA111147C2 (es)
WO (1) WO2011060083A1 (es)
ZA (1) ZA201203239B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11266600B2 (en) 2017-11-14 2022-03-08 Profem Gmbh Emulsions for the topical treatment of dermal and mucosal infections

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
CN104337952A (zh) * 2013-08-10 2015-02-11 李谊 一种中西医结合治疗爆震性耳聋的组合药物
CN104739768A (zh) * 2013-12-27 2015-07-01 河南惠通天下生物工程有限公司 一种甲砜霉素纳米脂质体及其制备方法
EP3482744A1 (de) * 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
BR112022005354A2 (pt) * 2019-09-23 2022-08-23 Dds Res Inc Composições de vesícula lipídica com agentes potencializadores de penetração
US20210106597A1 (en) * 2019-10-11 2021-04-15 Piedmont Animal Health Inc. Otic formulations, methods and devices
CN113876658B (zh) * 2021-11-01 2023-10-20 仙乐健康科技股份有限公司 水包油型乳液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT744939E (pt) 1994-02-04 2003-02-28 Lipocore Holding Ab Preparacoes em bicamada preparadas a partir de digalactosildiacilglicerol contendo galactolipido
EP0785780A1 (en) * 1994-10-10 1997-07-30 Novartis AG Ophthalmic and aural compositions containing diclofenac potassium
AU708540B2 (en) * 1995-06-06 1999-08-05 Bayer Intellectual Property Gmbh Non-irritation, nonsensitizing, non-ototoxic otic anti-bacterial compositions
IT1295369B1 (it) * 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6433024B1 (en) * 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
AUPR798901A0 (en) * 2001-09-28 2001-10-25 Medvet Science Pty. Ltd. Spheroidal hdl particles with a defined phospholipid composition
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20070054844A1 (en) * 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
US20070078116A1 (en) * 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
BRPI0514898A (pt) 2004-09-03 2008-06-24 Piedmont Pharmaceuticals Llc métodos para tratamento e prevenção transmembrana da otite média
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20090111780A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11266600B2 (en) 2017-11-14 2022-03-08 Profem Gmbh Emulsions for the topical treatment of dermal and mucosal infections

Also Published As

Publication number Publication date
RU2680137C2 (ru) 2019-02-18
AU2010319538A1 (en) 2012-05-17
IL219483A (en) 2017-12-31
CA2780160A1 (en) 2011-05-19
PT2498792T (pt) 2017-10-18
RU2012124067A (ru) 2013-12-20
LT2498792T (lt) 2017-10-25
NO2498792T3 (es) 2017-12-30
US8927006B2 (en) 2015-01-06
HUE034617T2 (en) 2018-02-28
MY162687A (en) 2017-07-14
NZ599559A (en) 2014-08-29
KR101901083B1 (ko) 2018-09-20
BR112012011017A2 (pt) 2015-09-15
HRP20171520T1 (hr) 2017-11-17
JP6138891B2 (ja) 2017-05-31
AU2010319538B2 (en) 2015-04-09
US20110281809A1 (en) 2011-11-17
ZA201203239B (en) 2013-07-31
WO2011060083A1 (en) 2011-05-19
CA2780160C (en) 2018-03-06
MX2012005521A (es) 2012-06-19
PL2498792T3 (pl) 2018-01-31
ES2645200T3 (es) 2017-12-04
CO6540004A2 (es) 2012-10-16
EP2498792A4 (en) 2013-06-12
DK2498792T3 (da) 2017-11-06
CN102612372A (zh) 2012-07-25
ECSP12011967A (es) 2012-08-31
EP2498792B1 (en) 2017-08-02
JP2016102112A (ja) 2016-06-02
SI2498792T1 (sl) 2017-11-30
KR20120116398A (ko) 2012-10-22
EP2498792A1 (en) 2012-09-19
KR20170100680A (ko) 2017-09-04
UA111147C2 (uk) 2016-04-11
IL219483A0 (en) 2012-06-28
CN102612372B (zh) 2016-01-20
JP2013510861A (ja) 2013-03-28

Similar Documents

Publication Publication Date Title
CL2012001227A1 (es) Composicion farmaceutica que comprende un portador de lipidos y al menos dos agentes activos selccionados entre antibioticos, antihongos, antiparasitarios, antivirales, antinflamatorios no esteroideos, analgesicos, anestesicos y esteroides; donde el portador lipidico es una emulsion lipidicadea aceite en agua, una microemulsion lipidica o una vesicula lipidica; uso en la infeccion por otitis externa.
ATE554746T1 (de) Pharmazeutische zusammensetzungen mit cyclosporin
UY30759A1 (es) Compuestos quimicos
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
AR088381A1 (es) Formulaciones de etanercept estabilizadas con meglumina
CL2011000135A1 (es) Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica.
ES2376043T3 (es) Derivados de indazol para el tratamiento de enfermedades inducidas por hsp90.
CL2010001406A1 (es) Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion.
CL2008001922A1 (es) Compuestos derivados de bencimidazol-2-piperidin, inhibidores de la ruta de señalizacion de las proteinas erizo; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos utiles en el tratamiento de estados de crecimiento celular anormal, tal como el cancer.
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
DOP2010000259A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
CL2007002228A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composiicon empacada; metodos para esterelizarlas; util para cicatrizar tejido donde la dermis se ha desgarrado.
BR112012018695A2 (pt) compostos pirazol como antagonistas crth2
RS54438B1 (en) PHARMACEUTICAL DOSAGE FORM CONTAINING 6`-FLUORO- (N-METHYL-OR N, N-DIMETHYL) - 4-PHENYL-4`, 9`-DIHYDRO-3`H-SPIRO [CYCLOHEXANE-1,1`-PIRANO [3,4, B] INDOL] -4-AMINE
AR059844A1 (es) Nuevas composiciones topicas en forma de emulsion ac/ag que comprenden un glicol propenetrante
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
AR059097A1 (es) Tratamiento a largo plazo de la infeccion por vih
UY31864A (es) Derivados de urea hetericíclica y métodos de uso de los mismos-332
RS53515B1 (en) A COMBINED COMPOSITION CONTAINING AS THE ACTIVE INGREDIENT OF L-CARNITIN OR PROPIONYL L-CARNITINE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENUAL INSUFFICIENCY
CL2010000524A1 (es) Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales.
CY1108869T1 (el) Φωτοσταθεροποιημενα τοπικα σκευασματα κετοπροφαινης που περιεχουν δυο φιλτρα uv
ECSP14010605A (es) Sistema para la administración de fármacos
CL2012003341A1 (es) Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades.
ES2525451T3 (es) Uso de óxido nitroso inhalado para prevenir el dolor neuropático inducido por sales de platino